DR. TRI MINH LE MD NPI 1205848033

NPI Details

DR. Tri Minh Le, MD is a family medicine in Coldspring, TX with 24 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Tri Minh Le, MD NPI is 1205848033. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

21 ALPINE ST
COLDSPRING, TX
ZIP 77331-058
Phone: (936) 647-2227
Fax: (936) 647-2202

The NPI 1205848033 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Urinalysis, manual test (HCPCS:81002)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Injection, lincomycin hcl, up to 300 mg (HCPCS:J2010)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Coronavirus vaccine 14 (HCPCS:91313)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to determine lung volumes using sensors (HCPCS:94726)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Test to measure the level of nitric oxide gas (HCPCS:95012)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 8/12/2006 and was last updated on 3/9/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.